Evaluating ivosidenib for the treatment of acute myeloid leukemia

M. L. DonkerDepartment of Haematology, Amsterdam UMC, Vrije Universiteit University Medical Center, Amsterdam, The NetherlandsCorrespondence[email protected]
View further author information

G. J. OssenkoppeleDepartment of Haematology, Amsterdam UMC, Vrije Universiteit University Medical Center, Amsterdam, The NetherlandsView further author information

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (7)

Dongmei Wang, Tao Sun, Yuan Xia, Zhe Zhao, Xue Sheng, Shuying Li, Yuechan Ma, Mingying Li, Xiuhua Su, Fan Zhang, Peng Li, Daoxin Ma, Jingjing Ye, Fei Lu & Chunyan Ji. (2023) Homodimer-mediated phosphorylation of C/EBPα-p42 S16 modulates acute myeloid leukaemia differentiation through liquid-liquid phase separation. Nature Communications 14:1.
Crossref

Alberto Quattrocchi, Luca Vincenzo Cappelli, Giovanna De Simone, Elisabetta De Marinis, Martina Gentile, Tecla Gasperi, Alessandro Pulsoni, Paolo Ascenzi & Clara Nervi. (2023) Biomarkers in acute myeloid leukemia: From state of the art in risk classification to future challenges of RNA editing as disease predictor and therapy target. Aspects of Molecular Medicine, pages 100023.
Crossref

Sophie Steinhäuser, Patricia Silva, Lennart Lenk, Thomas Beder, Alina Hartmann, Sonja Hänzelmann, Lars Fransecky, Martin Neumann, Lorenz Bastian, Simone Lipinski, Kathrin Richter, Miriam Bultmann, Emely Hübner, Shuli Xia, Christoph Röllig, Fotini Vogiatzi, Denis Martin Schewe, Veronica Yumiceba, Kristin Schultz, Malte Spielmann & Claudia Dorothea Baldus. (2022) Isocitrate dehydrogenase 1 mutation drives leukemogenesis by PDGFRA activation due to insulator disruption in acute myeloid leukemia (AML). Leukemia 37:1, pages 134-142.
Crossref

Devipriya Padmakumar, Vineetha Radhakrishnan Chandraprabha, Preethi Gopinath, Akhila Raj Thampirajan Vimala Devi, Geetha Raj John Anitha, Mahitha Mohanan Sreelatha, Amritha Padmakumar & Hariharan Sreedharan. (2021) A concise review on the molecular genetics of acute myeloid leukemia. Leukemia Research 111, pages 106727.
Crossref

Wohn-Jenn Leu, Hsun-Shuo Chang, Ih-Sheng Chen, Jih-Hwa Guh & She-Hung Chan. (2021) Antileukemic Natural Product Induced Both Apoptotic and Pyroptotic Programmed Cell Death and Differentiation Effect. International Journal of Molecular Sciences 22:20, pages 11239.
Crossref

Marium Khan, John T. Roddy, Jesus R. Hernandez, Karina Bursch, Naveet Bal, Karen S. Carlson & Paul A. Bergl. (2021) Revisiting biochemistry: severe euglycemic ketoacidosis in the setting of IDH‐inhibitor therapy for AML. British Journal of Haematology 194:6, pages 1083-1085.
Crossref

Ioann O. Popov, Maria V. Popova, Taras V. Omelian, Alexey V. Dobrydnev, Irina S. Konovalova, Svitlana V. Shishkina, Oleksandr O. Grygorenko & Yulian M. Volovenko. (2021) Reaction of Dialkylaminosulfur Trifluorides with β‐Keto Sulfonamides and β‐Keto Sulfones. ChemistrySelect 6:13, pages 3084-3088.
Crossref

Evaluating ivosidenib for the treatment of acute myeloid leukemia

Articles from other publishers (7)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Evaluating ivosidenib for the treatment of acute myeloid leukemia

Citations (7)

Articles from other publishers (7)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date